19th Annual International Ultmann Chicago Lymphoma Symposium
Playback speed
10 seconds
Debate: Auto-HCT Remains the Preferred Standard of Care for 1L Therapy of MCL
299 views
July 8, 2022
Comments 0
Login to view comments.
Click here to Login
Videos